株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の血友病治療市場規模:疾患別、製品別、患者別、処置別、治療別、薬剤クラス別、投与ルート別、エンドユース別、業界分析、地域別の見通し、潜在的用途、価格動向、競合市場シェアおよび予測

Hemophilia Treatment Market Size By Disease, Product, Patient, Treatment, Therapy, Drug Class, Route of Administration, End-use, Industry Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019-2025

発行 Global Market Insights Inc. 商品コード 882350
出版日 ページ情報 英文 660 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
世界の血友病治療市場規模:疾患別、製品別、患者別、処置別、治療別、薬剤クラス別、投与ルート別、エンドユース別、業界分析、地域別の見通し、潜在的用途、価格動向、競合市場シェアおよび予測 Hemophilia Treatment Market Size By Disease, Product, Patient, Treatment, Therapy, Drug Class, Route of Administration, End-use, Industry Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019-2025
出版日: 2019年06月14日 ページ情報: 英文 660 Pages
概要

当レポートでは、世界の血友病治療市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 調査方法

第2章 エグゼクティブサマリー

第3章 業界動向

  • 業界セグメンテーション
  • 業界環境
  • 業界影響因子
    • 成長促進因子
    • 落とし穴と課題
  • 成長可能性分析
  • 法規制環境
  • 世界の血友病罹患率
  • 製品パイプライン分析
  • ポーターズ分析
  • 競合環境
  • PESTEL分析

第4章 疾患別市場

  • 市場シェア
  • 血友病A
  • 血友病B
  • その他

第5章 製品別市場

  • 市場シェア
  • 組み換え因子濃縮物
  • 血漿由来因子濃縮物
  • 半減期拡張製品
  • その他

第6章 患者別市場

  • 市場シェア
  • 小児
  • 成人

第7章 処置別市場

  • 市場シェア
  • 予防
  • オンデマンド

第8章 治療別市場

  • 市場シェア
  • 因子補充療法
  • 非因子補充療法
  • その他

第9章 薬剤クラス別市場

  • 市場シェア
  • バソプレシン
  • 凝固因子

第10章 投与ルート別市場

  • 市場シェア
  • 注射
  • 鼻スプレー
  • その他

第10章 エンドユース別市場

  • 市場シェア
  • 病院
  • クリニック
  • 血友病治療センター
  • その他

第12章 地域別市場

  • 市場シェア
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第13章 企業プロファイル

  • Bayer Healthcare
  • Biogen
  • Biotest AG
  • CSL Behring
  • Ferring B.V.
  • Genentech
  • Kedrion
  • Novo Nordisk
  • Octapharma
  • Pfizer
  • Sanofi SA
  • Swedish Orphan Biovitrum AB
図表

Data Tables

  • TABLE 1: Hemophilia treatment industry 360 degree synopsis, 2014 - 2025
  • TABLE 2: Global hemophilia treatment market, 2014 - 2018 (USD Million)
  • TABLE 3: Global hemophilia treatment market, 2019 - 2025 (USD Million)
  • TABLE 4: Global hemophilia treatment market, by disease, 2014 - 2018 (USD Million)
  • TABLE 5: Global hemophilia treatment market, by disease, 2019 - 2025 (USD Million)
  • TABLE 6: Global hemophilia treatment market, by product, 2014 - 2018 (USD Million)
  • TABLE 7: Global hemophilia treatment market, by product, 2019 - 2025 (USD Million)
  • TABLE 8: Global hemophilia treatment market, by patient, 2014 - 2018 (USD Million)
  • TABLE 9: Global hemophilia treatment market, by patient, 2019 - 2025 (USD Million)
  • TABLE 10: Global hemophilia treatment market, by treatment, 2014 - 2018 (USD Million)
  • TABLE 11: Global hemophilia treatment market, by treatment, 2019 - 2025 (USD Million)
  • TABLE 12: Global hemophilia treatment market, by therapy, 2014 - 2018 (USD Million)
  • TABLE 13: Global hemophilia treatment market, by therapy, 2019 - 2025 (USD Million)
  • TABLE 14: Global hemophilia treatment market, by drug class, 2014 - 2018 (USD Million)
  • TABLE 15: Global hemophilia treatment market, by drug class, 2019 - 2025 (USD Million)
  • TABLE 16: Global hemophilia treatment market, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 17: Global hemophilia treatment market, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 18: Global hemophilia treatment market, by end-use, 2014 - 2018 (USD Million)
  • TABLE 19: Global hemophilia treatment market, by end-use, 2019 - 2025 (USD Million)
  • TABLE 20: Global hemophilia treatment market, by region, 2014 - 2018 (USD Million)
  • TABLE 21: Global hemophilia treatment market, by region, 2019 - 2025 (USD Million)
  • TABLE 22: Industry impact forces
  • TABLE 23: Factor concentrates product portfolio analysis
  • TABLE 24: Inhibitors product portfolio analysis
  • TABLE 25: Non-factor coagulation products product portfolio analysis
  • TABLE 26: Gene therapy product portfolio analysis
  • TABLE 27: Hemophilia A market size, by region, 2014 - 2018 (USD Million)
  • TABLE 28: Hemophilia A market size, by region, 2019 - 2025 (USD Million)
  • TABLE 29: Severe market size, by region, 2014 - 2018 (USD Million)
  • TABLE 30: Severe market size, by region, 2019 - 2025 (USD Million)
  • TABLE 31: Moderate market size, by region, 2014 - 2018 (USD Million)
  • TABLE 32: Moderate market size, by region, 2019 - 2025 (USD Million)
  • TABLE 33: Mild market size, by region, 2014 - 2018 (USD Million)
  • TABLE 34: Mild market size, by region, 2019 - 2025 (USD Million)
  • TABLE 35: Hemophilia B market size, by region, 2014 - 2018 (USD Million)
  • TABLE 36: Hemophilia B market size, by region, 2019 - 2025 (USD Million)
  • TABLE 37: Severe market size, by region, 2014 - 2018 (USD Million)
  • TABLE 38: Severe market size, by region, 2019 - 2025 (USD Million)
  • TABLE 39: Moderate market size, by region, 2014 - 2018 (USD Million)
  • TABLE 40: Moderate market size, by region, 2019 - 2025 (USD Million)
  • TABLE 41: Mild market size, by region, 2014 - 2018 (USD Million)
  • TABLE 42: Mild market size, by region, 2019 - 2025 (USD Million)
  • TABLE 43: Others market size, by region, 2014 - 2018 (USD Million)
  • TABLE 44: Mild market size, by region, 2019 - 2025 (USD Million)
  • TABLE 45: Recombinant factor concentrates market size, by region, 2014 - 2018 (USD Million)
  • TABLE 46: Recombinant factor concentrates market size, by region, 2019 - 2025 (USD Million)
  • TABLE 47: Factor VIII market size, by region, 2014 - 2018 (USD Million)
  • TABLE 48: Factor VIII market size, by region, 2019 - 2025 (USD Million)
  • TABLE 49: Factor IX market size, by region, 2014 - 2018 (USD Million)
  • TABLE 50: Moderate market size, by region, 2019 - 2025 (USD Million)
  • TABLE 51: Plasma-derived factor concentrates market size, by region, 2014 - 2018 (USD Million)
  • TABLE 52: Plasma-derived factor concentrates market size, by region, 2019 - 2025 (USD Million)
  • TABLE 53: Factor VIII market size, by region, 2014 - 2018 (USD Million)
  • TABLE 54: Factor VIII market size, by region, 2019 - 2025 (USD Million)
  • TABLE 55: Factor IX market size, by region, 2014 - 2018 (USD Million)
  • TABLE 56: Moderate market size, by region, 2019 - 2025 (USD Million)
  • TABLE 57: Extended half-life products market size, by region, 2014 - 2018 (USD Million)
  • TABLE 58: Extended half-life products market size, by region, 2019 - 2025 (USD Million)
  • TABLE 59: Factor VIII market size, by region, 2014 - 2018 (USD Million)
  • TABLE 60: Factor VIII market size, by region, 2019 - 2025 (USD Million)
  • TABLE 61: Factor IX market size, by region, 2014 - 2018 (USD Million)
  • TABLE 62: Moderate market size, by region, 2019 - 2025 (USD Million)
  • TABLE 63: Pediatric market size, by region, 2014 - 2018 (USD Million)
  • TABLE 64: Pediatric market size, by region, 2019 - 2025 (USD Million)
  • TABLE 65: 0 to 4 years market size, by region, 2014 - 2018 (USD Million)
  • TABLE 66: 0 to 4 years market size, by region, 2019 - 2025 (USD Million)
  • TABLE 67: 5 to 13 years market size, by region, 2014 - 2018 (USD Million)
  • TABLE 68: 5 to 13 years market size, by region, 2019 - 2025 (USD Million)
  • TABLE 69: 14 to 18 years market size, by region, 2014 - 2018 (USD Million)
  • TABLE 70: 14 to 18 years market size, by region, 2019 - 2025 (USD Million)
  • TABLE 71: Adult market size, by region, 2014 - 2018 (USD Million)
  • TABLE 72: Adult market size, by region, 2019 - 2025 (USD Million)
  • TABLE 73: 19 to 44 years market size, by region, 2014 - 2018 (USD Million)
  • TABLE 74: 19 to 44 years market size, by region, 2019 - 2025 (USD Million)
  • TABLE 75: 45+ years market size, by region, 2014 - 2018 (USD Million)
  • TABLE 76: 45+ years market size, by region, 2019 - 2025 (USD Million)
  • TABLE 77: Prophylaxis market size, by region, 2014 - 2018 (USD Million)
  • TABLE 78: Prophylaxis market size, by region, 2019 - 2025 (USD Million)
  • TABLE 79: On demand market size, by region, 2014 - 2018 (USD Million)
  • TABLE 80: On demand market size, by region, 2019 - 2025 (USD Million)
  • TABLE 81: Factor replacement therapy market size, by region, 2014 - 2018 (USD Million)
  • TABLE 82: Factor replacement therapy market size, by region, 2019 - 2025 (USD Million)
  • TABLE 83: Non-factor replacement therapy market size, by region, 2014 - 2018 (USD Million)
  • TABLE 84: Non-factor replacement therapy market size, by region, 2019 - 2025 (USD Million)
  • TABLE 85: Others market size, by region, 2014 - 2018 (USD Million)
  • TABLE 86: Others market size, by region, 2019 - 2025 (USD Million)
  • TABLE 87: Vasopressin market size, by region, 2014 - 2018 (USD Million)
  • TABLE 88: Vasopressin market size, by region, 2019 - 2025 (USD Million)
  • TABLE 89: Coagulation factors market size, by region, 2014 - 2018 (USD Million)
  • TABLE 90: Coagulation Factors market size, by region, 2019 - 2025 (USD Million)
  • TABLE 91: Injectable market size, by region, 2014 - 2018 (USD Million)
  • TABLE 92: Injectable market size, by region, 2019 - 2025 (USD Million)
  • TABLE 93: Nasal spray market size, by region, 2014 - 2018 (USD Million)
  • TABLE 94: Nasal spray market size, by region, 2019 - 2025 (USD Million)
  • TABLE 95: Others market size, by region, 2014 - 2018 (USD Million)
  • TABLE 96: Others market size, by region, 2019 - 2025 (USD Million)
  • TABLE 97: Hospitals market size, by region, 2014 - 2018 (USD Million)
  • TABLE 98: Hospitals market size, by region, 2019 - 2025 (USD Million)
  • TABLE 99: Clinics market size, by region, 2014 - 2018 (USD Million)
  • TABLE 100: Clinics market size, by region, 2019 - 2025 (USD Million)
  • TABLE 101: Hemophilia centers market size, by region, 2014 - 2018 (USD Million)
  • TABLE 102: Hemophilia centers market size, by region, 2019 - 2025 (USD Million)
  • TABLE 103: Others market size, by region, 2014 - 2018 (USD Million)
  • TABLE 104: Others market size, by region, 2019 - 2025 (USD Million)
  • TABLE 105: North America hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 106: North America hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 107: North America hemophilia treatment market size, by country, 2014 - 2018 (USD Million)
  • TABLE 108: North America hemophilia treatment market size, by country, 2019 - 2025 (USD Million)
  • TABLE 109: North America hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 110: North America hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 111: North America hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 112: North America hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 113: North America hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 114: North America hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 115: North America hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 116: North America hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 117: North America hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 118: North America hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 119: North America hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 120: North America hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 121: North America hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 122: North America hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 123: North America hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 124: North America hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 125: North America hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 126: North America hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 127: North America hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 128: North America hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 129: North America hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 130: North America hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 131: North America hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 132: North America hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 133: North America hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 134: North America hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 135: North America hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 136: North America hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 137: North America hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 138: North America hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 139: U.S. hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 140: U.S. hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 141: U.S. hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 142: U.S. hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 143: U.S. hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 144: U.S. hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 145: U.S. hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 146: U.S. hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 147: U.S. hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 148: U.S. hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 149: U.S. hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 150: U.S. hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 151: U.S. hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 152: U.S. hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 153: U.S. hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 154: U.S. hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 155: U.S. hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 156: U.S. hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 157: U.S. hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 158: U.S. hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 159: U.S. hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 160: U.S. hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 161: U.S. hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 162: U.S. hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 163: U.S. hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 164: U.S. hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 165: U.S. hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 166: U.S. hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 167: U.S. hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 168: U.S. hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 169: U.S. hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 170: U.S. hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 171: Canada hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 172: Canada hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 173: Canada hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 174: Canada hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 175: Canada hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 176: Canada hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 177: Canada hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 178: Canada hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 179: Canada hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 180: Canada hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 181: Canada hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 182: Canada hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 183: Canada hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 184: Canada hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 185: Canada hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 186: Canada hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 187: Canada hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 188: Canada hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 189: Canada hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 190: Canada hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 191: Canada hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 192: Canada hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 193: Canada hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 194: Canada hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 195: Canada hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 196: Canada hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 197: Canada hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 198: Canada hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 199: Canada hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 200: Canada hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 201: Canada hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 202: Canada hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 203: Europe hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 204: Europe hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 205: Europe hemophilia treatment market size, by country, 2014 - 2018 (USD Million)
  • TABLE 206: Europe hemophilia treatment market size, by country, 2019 - 2025 (USD Million)
  • TABLE 207: Europe hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 208: Europe hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 209: Europe hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 210: Europe hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 211: Europe hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 212: Europe hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 213: Europe hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 214: Europe hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 215: Europe hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 216: Europe hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 217: Europe hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 218: Europe hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 219: Europe hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 220: Europe hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 221: Europe hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 222: Europe hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 223: Europe hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 224: Europe hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 225: Europe hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 226: Europe hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 227: Europe hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 228: Europe hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 229: Europe hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 230: Europe hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 231: Europe hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 232: Europe hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 233: Europe hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 234: Europe hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 235: Europe hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 236: Europe hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 237: Germany hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 238: Germany hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 239: Germany hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 240: Germany hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 241: Germany hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 242: Germany hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 243: Germany hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 244: Germany hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 245: Germany hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 246: Germany hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 247: Germany hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 248: Germany hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 249: Germany hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 250: Germany hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 251: Germany hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 252: Germany hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 253: Germany hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 254: Germany hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 255: Germany hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 256: Germany hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 257: Germany hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 258: Germany hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 259: Germany hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 260: Germany hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 261: Germany hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 262: Germany hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 263: Germany hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 264: Germany hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 265: Germany hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 266: Germany hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 267: Germany hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 268: Germany hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 269: UK hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 270: UK hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 271: UK hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 272: UK hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 273: UK hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 274: UK hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 275: UK hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 276: UK hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 277: UK hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 278: UK hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 279: UK hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 280: UK hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 281: UK hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 282: UK hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 283: UK hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 284: UK hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 285: UK hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 286: UK hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 287: UK hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 288: UK hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 289: UK hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 290: UK hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 291: UK hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 292: UK hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 293: UK hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 294: UK hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 295: UK hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 296: UK hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 297: UK hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 298: UK hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 299: UK hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 300: UK hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 301: France hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 302: France hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 303: France hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 304: France hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 305: France hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 306: France hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 307: France hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 308: France hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 309: France hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 310: France hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 311: France hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 312: France hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 313: France hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 314: France hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 315: France hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 316: France hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 317: France hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 318: France hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 319: France hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 320: France hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 321: France hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 322: France hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 323: France hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 324: France hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 325: France hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 326: France hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 327: France hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 328: France hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 329: France hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 330: France hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 331: France hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 332: France hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 333: Spain hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 334: Spain hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 335: Spain hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 336: Spain hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 337: Spain hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 338: Spain hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 339: Spain hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 340: Spain hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 341: Spain hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 342: Spain hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 343: Spain hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 344: Spain hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 345: Spain hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 346: Spain hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 347: Spain hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 348: Spain hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 349: Spain hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 350: Spain hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 351: Spain hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 352: Spain hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 353: Spain hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 354: Spain hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 355: Spain hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 356: Spain hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 357: Spain hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 358: Spain hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 359: Spain hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 360: Spain hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 361: Spain hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 362: Spain hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 363: Spain hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 364: Spain hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 365: Italy hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 366: Italy hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 367: Italy hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 368: Italy hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 369: Italy hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 370: Italy hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 371: Italy hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 372: Italy hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 373: Italy hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 374: Italy hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 375: Italy hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 376: Italy hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 377: Italy hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 378: Italy hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 379: Italy hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 380: Italy hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 381: Italy hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 382: Italy hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 383: Italy hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 384: Italy hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 385: Italy hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 386: Italy hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 387: Italy hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 388: Italy hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 389: Italy hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 390: Italy hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 391: Italy hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 392: Italy hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 393: Italy hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 394: Italy hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 395: Italy hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 396: Italy hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 397: Russia hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 398: Russia hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 399: Russia hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 400: Russia hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 401: Russia hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 402: Russia hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 403: Russia hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 404: Russia hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 405: Russia hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 406: Russia hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 407: Russia hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 408: Russia hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 409: Russia hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 410: Russia hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 411: Russia hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 412: Russia hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 413: Russia hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 414: Russia hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 415: Russia hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 416: Russia hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 417: Russia hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 418: Russia hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 419: Russia hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 420: Russia hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 421: Russia hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 422: Russia hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 423: Russia hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 424: Russia hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 425: Russia hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 426: Russia hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 427: Russia hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 428: Russia hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 429: Poland hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 430: Poland hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 431: Poland hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 432: Poland hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 433: Poland hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 434: Poland hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 435: Poland hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 436: Poland hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 437: Poland hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 438: Poland hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 439: Poland hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 440: Poland hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 441: Poland hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 442: Poland hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 443: Poland hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 444: Poland hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 445: Poland hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 446: Poland hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 447: Poland hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 448: Poland hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 449: Poland hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 450: Poland hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 451: Poland hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 452: Poland hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 453: Poland hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 454: Poland hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 455: Poland hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 456: Poland hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 457: Poland hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 458: Poland hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 459: Poland hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 460: Poland hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 461: Hungary hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 462: Hungary hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 463: Hungary hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 464: Hungary hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 465: Hungary hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 466: Hungary hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 467: Hungary hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 468: Hungary hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 469: Hungary hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 470: Hungary hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 471: Hungary hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 472: Hungary hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 473: Hungary hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 474: Hungary hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 475: Hungary hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 476: Hungary hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 477: Hungary hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 478: Hungary hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 479: Hungary hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 480: Hungary hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 481: Hungary hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 482: Hungary hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 483: Hungary hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 484: Hungary hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 485: Hungary hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 486: Hungary hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 487: Hungary hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 488: Hungary hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 489: Hungary hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 490: Hungary hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 491: Hungary hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 492: Hungary hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 493: Czech Republic hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 494: Czech Republic hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 495: Czech Republic hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 496: Czech Republic hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 497: Czech Republic hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 498: Czech Republic hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 499: Czech Republic hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 500: Czech Republic hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 501: Czech Republic hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 502: Czech Republic hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 503: Czech Republic hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 504: Czech Republic hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 505: Czech Republic hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 506: Czech Republic hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 507: Czech Republic hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 508: Czech Republic hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 509: Czech Republic hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 510: Czech Republic hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 511: Czech Republic hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 512: Czech Republic hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 513: Czech Republic hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 514: Czech Republic hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 515: Czech Republic hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 516: Czech Republic hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 517: Czech Republic hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 518: Czech Republic hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 519: Czech Republic hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 520: Czech Republic hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 521: Czech Republic hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 522: Czech Republic hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 523: Czech Republic hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 524: Czech Republic hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 525: Finland hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 526: Finland hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 527: Finland hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 528: Finland hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 529: Finland hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 530: Finland hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 531: Finland hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 532: Finland hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 533: Finland hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 534: Finland hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 535: Finland hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 536: Finland hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 537: Finland hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 538: Finland hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 539: Finland hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 540: Finland hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 541: Finland hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 542: Finland hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 543: Finland hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 544: Finland hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 545: Finland hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 546: Finland hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 547: Finland hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 548: Finland hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 549: Finland hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 550: Finland hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 551: Finland hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 552: Finland hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 553: Finland hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 554: Finland hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 555: Finland hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 556: Finland hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 557: Greece hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 558: Greece hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 559: Greece hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 560: Greece hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 561: Greece hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 562: Greece hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 563: Greece hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 564: Greece hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 565: Greece hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 566: Greece hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 567: Greece hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 568: Greece hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 569: Greece hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 570: Greece hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 571: Greece hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 572: Greece hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 573: Greece hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 574: Greece hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 575: Greece hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 576: Greece hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 577: Greece hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 578: Greece hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 579: Greece hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 580: Greece hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 581: Greece hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 582: Greece hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 583: Greece hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 584: Greece hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 585: Greece hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 586: Greece hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 587: Greece hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 588: Greece hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 589: Ireland hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 590: Ireland hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 591: Ireland hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 592: Ireland hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 593: Ireland hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 594: Ireland hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 595: Ireland hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 596: Ireland hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 597: Ireland hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 598: Ireland hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 599: Ireland hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 600: Ireland hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 601: Ireland hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 602: Ireland hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 603: Ireland hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 604: Ireland hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 605: Ireland hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 606: Ireland hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 607: Ireland hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 608: Ireland hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 609: Ireland hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 610: Ireland hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 611: Ireland hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 612: Ireland hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 613: Ireland hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 614: Ireland hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 615: Ireland hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 616: Ireland hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 617: Ireland hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 618: Ireland hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 619: Ireland hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 620: Ireland hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 621: Portugal hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 622: Portugal hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 623: Portugal hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 624: Portugal hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 625: Portugal hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 626: Portugal hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 627: Portugal hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 628: Portugal hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 629: Portugal hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 630: Portugal hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 631: Portugal hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 632: Portugal hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 633: Portugal hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 634: Portugal hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 635: Portugal hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 636: Portugal hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 637: Portugal hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 638: Portugal hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 639: Portugal hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 640: Portugal hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 641: Portugal hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 642: Portugal hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 643: Portugal hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 644: Portugal hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 645: Portugal hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 646: Portugal hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 647: Portugal hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 648: Portugal hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 649: Portugal hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 650: Portugal hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 651: Portugal hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 652: Portugal hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 653: Sweden hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 654: Sweden hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 655: Sweden hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 656: Sweden hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 657: Sweden hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 658: Sweden hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 659: Sweden hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 660: Sweden hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 661: Sweden hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 662: Sweden hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 663: Sweden hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 664: Sweden hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 665: Sweden hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 666: Sweden hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 667: Sweden hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 668: Sweden hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 669: Sweden hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 670: Sweden hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 671: Sweden hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 672: Sweden hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 673: Sweden hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 674: Sweden hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 675: Sweden hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 676: Sweden hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 677: Sweden hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 678: Sweden hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 679: Sweden hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 680: Sweden hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 681: Sweden hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 682: Sweden hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 683: Sweden hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 684: Sweden hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 685: Switzerland hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 686: Switzerland hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 687: Switzerland hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 688: Switzerland hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 689: Switzerland hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 690: Switzerland hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 691: Switzerland hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 692: Switzerland hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 693: Switzerland hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 694: Switzerland hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 695: Switzerland hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 696: Switzerland hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 697: Switzerland hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 698: Switzerland hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 699: Switzerland hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 700: Switzerland hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 701: Switzerland hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 702: Switzerland hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 703: Switzerland hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 704: Switzerland hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 705: Switzerland hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 706: Switzerland hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 707: Switzerland hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 708: Switzerland hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 709: Switzerland hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 710: Switzerland hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 711: Switzerland hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 712: Switzerland hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 713: Switzerland hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 714: Switzerland hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 715: Switzerland hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 716: Switzerland hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 717: Ukraine hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 718: Ukraine hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 719: Ukraine hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 720: Ukraine hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 721: Ukraine hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 722: Ukraine hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 723: Ukraine hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 724: Ukraine hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 725: Ukraine hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 726: Ukraine hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 727: Ukraine hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 728: Ukraine hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 729: Ukraine hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 730: Ukraine hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 731: Ukraine hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 732: Ukraine hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 733: Ukraine hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 734: Ukraine hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 735: Ukraine hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 736: Ukraine hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 737: Ukraine hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 738: Ukraine hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 739: Ukraine hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 740: Ukraine hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 741: Ukraine hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 742: Ukraine hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 743: Ukraine hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 744: Ukraine hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 745: Ukraine hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 746: Ukraine hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 747: Ukraine hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 748: Ukraine hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 749: Norway hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 750: Norway hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 751: Norway hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 752: Norway hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 753: Norway hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 754: Norway hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 755: Norway hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 756: Norway hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 757: Norway hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 758: Norway hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 759: Norway hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 760: Norway hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 761: Norway hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 762: Norway hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 763: Norway hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 764: Norway hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 765: Norway hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 766: Norway hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 767: Norway hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 768: Norway hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 769: Norway hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 770: Norway hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 771: Norway hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 772: Norway hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 773: Norway hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 774: Norway hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 775: Norway hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 776: Norway hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 777: Norway hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 778: Norway hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 779: Norway hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 780: Norway hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 781: Slovakia hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 782: Slovakia hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 783: Slovakia hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 784: Slovakia hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 785: Slovakia hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 786: Slovakia hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 787: Slovakia hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 788: Slovakia hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 789: Slovakia hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 790: Slovakia hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 791: Slovakia hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 792: Slovakia hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 793: Slovakia hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 794: Slovakia hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 795: Slovakia hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 796: Slovakia hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 797: Slovakia hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 798: Slovakia hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 799: Slovakia hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 800: Slovakia hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 801: Slovakia hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 802: Slovakia hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 803: Slovakia hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 804: Slovakia hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 805: Slovakia hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 806: Slovakia hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 807: Slovakia hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 808: Slovakia hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 809: Slovakia hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 810: Slovakia hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 811: Slovakia hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 812: Slovakia hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 813: Asia Pacific hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 814: Asia Pacific hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 815: Asia Pacific hemophilia treatment market size, by country, 2014 - 2018 (USD Million)
  • TABLE 816: Asia Pacific hemophilia treatment market size, by country, 2019 - 2025 (USD Million)
  • TABLE 817: Asia Pacific hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 818: Asia Pacific hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 819: Asia Pacific hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 820: Asia Pacific hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 821: Asia Pacific hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 822: Asia Pacific hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 823: Asia Pacific hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 824: Asia Pacific hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 825: Asia Pacific hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 826: Asia Pacific hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 827: Asia Pacific hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 828: Asia Pacific hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 829: Asia Pacific hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 830: Asia Pacific hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 831: Asia Pacific hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 832: Asia Pacific hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 833: Asia Pacific hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 834: Asia Pacific hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 835: Asia Pacific hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 836: Asia Pacific hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 837: Asia Pacific hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 838: Asia Pacific hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 839: Asia Pacific hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 840: Asia Pacific hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 841: Asia Pacific hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 842: Asia Pacific hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 843: Asia Pacific hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 844: Asia Pacific hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 845: Asia Pacific hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 846: Asia Pacific hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 847: China hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 848: China hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 849: China hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 850: China hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 851: China hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 852: China hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 853: China hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 854: China hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 855: China hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 856: China hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 857: China hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 858: China hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 859: China hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 860: China hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 861: China hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 862: China hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 863: China hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 864: China hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 865: China hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 866: China hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 867: China hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 868: China hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 869: China hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 870: China hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 871: China hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 872: China hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 873: China hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 874: China hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 875: China hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 876: China hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 877: China hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 878: China hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 879: Japan hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 880: Japan hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 881: Japan hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 882: Japan hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 883: Japan hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 884: Japan hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 885: Japan hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 886: Japan hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 887: Japan hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 888: Japan hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 889: Japan hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 890: Japan hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 891: Japan hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 892: Japan hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 893: Japan hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 894: Japan hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 895: Japan hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 896: Japan hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 897: Japan hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 898: Japan hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 899: Japan hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 900: Japan hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 901: Japan hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 902: Japan hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 903: Japan hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 904: Japan hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 905: Japan hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 906: Japan hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 907: Japan hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 908: Japan hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 909: Japan hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 910: Japan hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 911: India hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 912: India hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 913: India hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 914: India hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 915: India hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 916: India hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 917: India hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 918: India hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 919: India hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 920: India hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 921: India hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 922: India hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 923: India hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 924: India hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 925: India hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 926: India hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 927: India hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 928: India hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 929: India hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 930: India hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 931: India hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 932: India hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 933: India hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 934: India hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 935: India hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 936: India hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 937: India hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 938: India hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 939: India hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 940: India hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 941: India hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 942: India hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 943: Australia hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 944: Australia hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 945: Australia hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 946: Australia hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 947: Australia hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 948: Australia hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 949: Australia hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 950: Australia hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 951: Australia hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 952: Australia hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 953: Australia hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 954: Australia hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 955: Australia hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 956: Australia hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 957: Australia hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 958: Australia hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 959: Australia hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 960: Australia hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 961: Australia hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 962: Australia hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 963: Australia hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 964: Australia hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 965: Australia hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 966: Australia hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 967: Australia hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 968: Australia hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 969: Australia hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 970: Australia hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 971: Australia hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 972: Australia hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 973: Australia hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 974: Australia hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 975: South Korea hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 976: South Korea hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 977: South Korea hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 978: South Korea hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 979: South Korea hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 980: South Korea hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 981: South Korea hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 982: South Korea hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 983: South Korea hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 984: South Korea hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 985: South Korea hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 986: South Korea hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 987: South Korea hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 988: South Korea hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 989: South Korea hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 990: South Korea hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 991: South Korea hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 992: South Korea hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 993: South Korea hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 994: South Korea hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 995: South Korea hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 996: South Korea hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 997: South Korea hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 998: South Korea hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 999: South Korea hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1000: South Korea hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1001: South Korea hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1002: South Korea hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1003: South Korea hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1004: South Korea hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1005: South Korea hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1006: South Korea hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1007: Malaysia hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1008: Malaysia hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1009: Malaysia hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1010: Malaysia hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1011: Malaysia hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1012: Malaysia hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1013: Malaysia hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1014: Malaysia hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1015: Malaysia hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1016: Malaysia hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1017: Malaysia hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1018: Malaysia hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1019: Malaysia hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1020: Malaysia hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1021: Malaysia hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1022: Malaysia hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1023: Malaysia hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1024: Malaysia hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1025: Malaysia hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1026: Malaysia hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1027: Malaysia hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1028: Malaysia hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1029: Malaysia hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1030: Malaysia hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1031: Malaysia hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1032: Malaysia hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1033: Malaysia hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1034: Malaysia hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1035: Malaysia hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1036: Malaysia hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1037: Malaysia hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1038: Malaysia hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1039: Philippines hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1040: Philippines hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1041: Philippines hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1042: Philippines hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1043: Philippines hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1044: Philippines hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1045: Philippines hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1046: Philippines hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1047: Philippines hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1048: Philippines hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1049: Philippines hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1050: Philippines hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1051: Philippines hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1052: Philippines hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1053: Philippines hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1054: Philippines hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1055: Philippines hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1056: Philippines hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1057: Philippines hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1058: Philippines hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1059: Philippines hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1060: Philippines hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1061: Philippines hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1062: Philippines hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1063: Philippines hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1064: Philippines hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1065: Philippines hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1066: Philippines hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1067: Philippines hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1068: Philippines hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1069: Philippines hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1070: Philippines hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1071: Thailand hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1072: Thailand hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1073: Thailand hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1074: Thailand hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1075: Thailand hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1076: Thailand hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1077: Thailand hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1078: Thailand hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1079: Thailand hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1080: Thailand hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1081: Thailand hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1082: Thailand hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1083: Thailand hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1084: Thailand hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1085: Thailand hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1086: Thailand hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1087: Thailand hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1088: Thailand hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1089: Thailand hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1090: Thailand hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1091: Thailand hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1092: Thailand hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1093: Thailand hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1094: Thailand hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1095: Thailand hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1096: Thailand hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1097: Thailand hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1098: Thailand hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1099: Thailand hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1100: Thailand hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1101: Thailand hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1102: Thailand hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1103: Vietnam hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1104: Vietnam hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1105: Vietnam hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1106: Vietnam hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1107: Vietnam hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1108: Vietnam hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1109: Vietnam hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1110: Vietnam hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1111: Vietnam hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1112: Vietnam hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1113: Vietnam hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1114: Vietnam hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1115: Vietnam hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1116: Vietnam hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1117: Vietnam hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1118: Vietnam hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1119: Vietnam hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1120: Vietnam hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1121: Vietnam hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1122: Vietnam hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1123: Vietnam hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1124: Vietnam hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1125: Vietnam hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1126: Vietnam hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1127: Vietnam hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1128: Vietnam hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1129: Vietnam hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1130: Vietnam hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1131: Vietnam hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1132: Vietnam hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1133: Vietnam hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1134: Vietnam hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1135: Singapore hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1136: Singapore hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1137: Singapore hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1138: Singapore hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1139: Singapore hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1140: Singapore hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1141: Singapore hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1142: Singapore hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1143: Singapore hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1144: Singapore hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1145: Singapore hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1146: Singapore hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1147: Singapore hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1148: Singapore hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1149: Singapore hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1150: Singapore hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1151: Singapore hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1152: Singapore hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1153: Singapore hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1154: Singapore hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1155: Singapore hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1156: Singapore hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1157: Singapore hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1158: Singapore hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1159: Singapore hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1160: Singapore hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1161: Singapore hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1162: Singapore hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1163: Singapore hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1164: Singapore hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1165: Singapore hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1166: Singapore hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1167: Latin America hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1168: Latin America hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1169: Latin America hemophilia treatment market size, by country, 2014 - 2018 (USD Million)
  • TABLE 1170: Latin America hemophilia treatment market size, by country, 2019 - 2025 (USD Million)
  • TABLE 1171: Latin America hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1172: Latin America hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1173: Latin America hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1174: Latin America hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1175: Latin America hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1176: Latin America hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1177: Latin America hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1178: Latin America hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1179: Latin America hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1180: Latin America hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1181: Latin America hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1182: Latin America hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1183: Latin America hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1184: Latin America hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1185: Latin America hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1186: Latin America hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1187: Latin America hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1188: Latin America hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1189: Latin America hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1190: Latin America hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1191: Latin America hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1192: Latin America hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1193: Latin America hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1194: Latin America hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1195: Latin America hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1196: Latin America hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1197: Latin America hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1198: Latin America hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1199: Latin America hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1200: Latin America hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1201: Brazil hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1202: Brazil hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1203: Brazil hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1204: Brazil hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1205: Brazil hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1206: Brazil hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1207: Brazil hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1208: Brazil hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1209: Brazil hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1210: Brazil hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1211: Brazil hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1212: Brazil hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1213: Brazil hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1214: Brazil hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1215: Brazil hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1216: Brazil hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1217: Brazil hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1218: Brazil hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1219: Brazil hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1220: Brazil hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1221: Brazil hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1222: Brazil hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1223: Brazil hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1224: Brazil hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1225: Brazil hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1226: Brazil hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1227: Brazil hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1228: Brazil hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1229: Brazil hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1230: Brazil hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1231: Brazil hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1232: Brazil hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1233: Mexico hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1234: Mexico hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1235: Mexico hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1236: Mexico hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1237: Mexico hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1238: Mexico hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1239: Mexico hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1240: Mexico hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1241: Mexico hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1242: Mexico hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1243: Mexico hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1244: Mexico hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1245: Mexico hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1246: Mexico hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1247: Mexico hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1248: Mexico hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1249: Mexico hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1250: Mexico hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1251: Mexico hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1252: Mexico hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1253: Mexico hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1254: Mexico hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1255: Mexico hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1256: Mexico hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1257: Mexico hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1258: Mexico hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1259: Mexico hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1260: Mexico hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1261: Mexico hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1262: Mexico hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1263: Mexico hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1264: Mexico hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1265: Argentina hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1266: Argentina hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1267: Argentina hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1268: Argentina hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1269: Argentina hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1270: Argentina hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1271: Argentina hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1272: Argentina hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1273: Argentina hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1274: Argentina hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1275: Argentina hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1276: Argentina hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1277: Argentina hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1278: Argentina hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1279: Argentina hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1280: Argentina hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1281: Argentina hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1282: Argentina hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1283: Argentina hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1284: Argentina hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1285: Argentina hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1286: Argentina hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1287: Argentina hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1288: Argentina hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1289: Argentina hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1290: Argentina hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1291: Argentina hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1292: Argentina hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1293: Argentina hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1294: Argentina hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1295: Argentina hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1296: Argentina hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1297: Columbia hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1298: Columbia hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1299: Columbia hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1300: Columbia hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1301: Columbia hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1302: Columbia hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1303: Columbia hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1304: Columbia hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1305: Columbia hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1306: Columbia hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1307: Columbia hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1308: Columbia hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1309: Columbia hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1310: Columbia hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1311: Columbia hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1312: Columbia hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1313: Columbia hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1314: Columbia hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1315: Columbia hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1316: Columbia hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1317: Columbia hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1318: Columbia hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1319: Columbia hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1320: Columbia hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1321: Columbia hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1322: Columbia hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1323: Columbia hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1324: Columbia hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1325: Columbia hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1326: Columbia hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1327: Columbia hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1328: Columbia hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1329: Chile hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1330: Chile hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1331: Chile hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1332: Chile hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1333: Chile hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1334: Chile hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1335: Chile hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1336: Chile hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1337: Chile hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1338: Chile hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1339: Chile hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1340: Chile hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1341: Chile hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1342: Chile hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1343: Chile hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1344: Chile hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1345: Chile hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1346: Chile hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1347: Chile hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1348: Chile hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1349: Chile hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1350: Chile hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1351: Chile hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1352: Chile hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1353: Chile hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1354: Chile hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1355: Chile hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1356: Chile hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1357: Chile hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1358: Chile hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1359: Chile hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1360: Chile hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1361: Venezuela hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1362: Venezuela hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1363: Venezuela hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1364: Venezuela hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1365: Venezuela hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1366: Venezuela hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1367: Venezuela hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1368: Venezuela hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1369: Venezuela hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1370: Venezuela hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1371: Venezuela hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1372: Venezuela hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1373: Venezuela hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1374: Venezuela hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1375: Venezuela hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1376: Venezuela hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1377: Venezuela hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1378: Venezuela hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1379: Venezuela hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1380: Venezuela hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1381: Venezuela hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1382: Venezuela hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1383: Venezuela hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1384: Venezuela hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1385: Venezuela hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1386: Venezuela hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1387: Venezuela hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1388: Venezuela hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1389: Venezuela hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1390: Venezuela hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1391: Venezuela hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1392: Venezuela hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1393: MEA hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1394: MEA hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1395: MEA hemophilia treatment market size, by country, 2014 - 2018 (USD Million)
  • TABLE 1396: MEA hemophilia treatment market size, by country, 2019 - 2025 (USD Million)
  • TABLE 1397: MEA hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1398: MEA hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1399: MEA hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1400: MEA hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1401: MEA hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1402: MEA hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1403: MEA hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1404: MEA hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1405: MEA hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1406: MEA hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1407: MEA hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1408: MEA hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1409: MEA hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1410: MEA hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1411: MEA hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1412: MEA hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1413: MEA hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1414: MEA hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1415: MEA hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1416: MEA hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1417: MEA hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1418: MEA hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1419: MEA hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1420: MEA hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1421: MEA hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1422: MEA hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1423: MEA hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1424: MEA hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1425: MEA hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1426: MEA hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1427: South Africa hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1428: South Africa hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1429: South Africa hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1430: South Africa hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1431: South Africa hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1432: South Africa hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1433: South Africa hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1434: South Africa hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1435: South Africa hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1436: South Africa hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1437: South Africa hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1438: South Africa hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1439: South Africa hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1440: South Africa hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1441: South Africa hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1442: South Africa hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1443: South Africa hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1444: South Africa hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1445: South Africa hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1446: South Africa hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1447: South Africa hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1448: South Africa hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1449: South Africa hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1450: South Africa hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1451: South Africa hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1452: South Africa hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1453: South Africa hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1454: South Africa hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1455: South Africa hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1456: South Africa hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1457: South Africa hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1458: South Africa hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1459: Saudi Arabia hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1460: Saudi Arabia hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1461: Saudi Arabia hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1462: Saudi Arabia hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1463: Saudi Arabia hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1464: Saudi Arabia hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1465: Saudi Arabia hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1466: Saudi Arabia hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1467: Saudi Arabia hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1468: Saudi Arabia hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1469: Saudi Arabia hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1470: Saudi Arabia hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1471: Saudi Arabia hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1472: Saudi Arabia hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1473: Saudi Arabia hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1474: Saudi Arabia hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1475: Saudi Arabia hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1476: Saudi Arabia hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1477: Saudi Arabia hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1478: Saudi Arabia hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1479: Saudi Arabia hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1480: Saudi Arabia hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1481: Saudi Arabia hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1482: Saudi Arabia hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1483: Saudi Arabia hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1484: Saudi Arabia hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1485: Saudi Arabia hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1486: Saudi Arabia hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1487: Saudi Arabia hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1488: Saudi Arabia hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1489: Saudi Arabia hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1490: Saudi Arabia hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1491: Egypt hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1492: Egypt hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1493: Egypt hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1494: Egypt hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1495: Egypt hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1496: Egypt hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1497: Egypt hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1498: Egypt hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1499: Egypt hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1500: Egypt hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1501: Egypt hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1502: Egypt hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1503: Egypt hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1504: Egypt hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1505: Egypt hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1506: Egypt hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1507: Egypt hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1508: Egypt hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1509: Egypt hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1510: Egypt hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1511: Egypt hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1512: Egypt hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1513: Egypt hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1514: Egypt hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1515: Egypt hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1516: Egypt hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1517: Egypt hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1518: Egypt hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1519: Egypt hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1520: Egypt hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1521: Egypt hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1522: Egypt hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1523: Iran hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1524: Iran hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1525: Iran hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1526: Iran hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1527: Iran hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1528: Iran hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1529: Iran hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1530: Iran hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1531: Iran hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1532: Iran hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1533: Iran hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1534: Iran hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1535: Iran hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1536: Iran hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1537: Iran hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1538: Iran hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1539: Iran hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1540: Iran hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1541: Iran hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1542: Iran hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1543: Iran hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1544: Iran hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1545: Iran hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1546: Iran hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1547: Iran hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1548: Iran hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1549: Iran hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1550: Iran hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1551: Iran hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1552: Iran hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1553: Iran hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1554: Iran hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1555: Iraq hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1556: Iraq hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1557: Iraq hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1558: Iraq hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1559: Iraq hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1560: Iraq hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1561: Iraq hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1562: Iraq hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1563: Iraq hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1564: Iraq hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1565: Iraq hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1566: Iraq hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1567: Iraq hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1568: Iraq hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1569: Iraq hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1570: Iraq hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1571: Iraq hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1572: Iraq hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1573: Iraq hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1574: Iraq hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1575: Iraq hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1576: Iraq hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1577: Iraq hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1578: Iraq hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1579: Iraq hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1580: Iraq hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1581: Iraq hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1582: Iraq hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1583: Iraq hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1584: Iraq hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1585: Iraq hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1586: Iraq hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 1587: UAE hemophilia prevalence, by disease, 2014 - 2018
  • TABLE 1588: UAE hemophilia prevalence, by disease, 2019 - 2025
  • TABLE 1589: UAE hemophilia treatment market size, by disease, 2014 - 2018 (USD Million)
  • TABLE 1590: UAE hemophilia treatment market size, by disease, 2019 - 2025 (USD Million)
  • TABLE 1591: UAE hemophilia treatment market size, by hemophilia A, 2014 - 2018 (USD Million)
  • TABLE 1592: UAE hemophilia treatment market size, by hemophilia A, 2019 - 2025 (USD Million)
  • TABLE 1593: UAE hemophilia treatment market size, by hemophilia B, 2014 - 2018 (USD Million)
  • TABLE 1594: UAE hemophilia treatment market size, by hemophilia B, 2019 - 2025 (USD Million)
  • TABLE 1595: UAE hemophilia treatment market size, by product, 2014 - 2018 (USD Million)
  • TABLE 1596: UAE hemophilia treatment market size, by product, 2019 - 2025 (USD Million)
  • TABLE 1597: UAE hemophilia treatment market size, by recombinant factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1598: UAE hemophilia treatment market size, by recombinant factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1599: UAE hemophilia treatment market size, by plasma-derived factor concentrates, 2014 - 2018 (USD Million)
  • TABLE 1600: UAE hemophilia treatment market size, by plasma-derived factor concentrates, 2019 - 2025 (USD Million)
  • TABLE 1601: UAE hemophilia treatment market size, by extended half-life products, 2014 - 2018 (USD Million)
  • TABLE 1602: UAE hemophilia treatment market size, by extended half-life products, 2019 - 2025 (USD Million)
  • TABLE 1603: UAE hemophilia treatment market size, by patient, 2014 - 2018 (USD Million)
  • TABLE 1604: UAE hemophilia treatment market size, by patient, 2019 - 2025 (USD Million)
  • TABLE 1605: UAE hemophilia treatment market size, by pediatric, 2014 - 2018 (USD Million)
  • TABLE 1606: UAE hemophilia treatment market size, by pediatric, 2019 - 2025 (USD Million)
  • TABLE 1607: UAE hemophilia treatment market size, by adult, 2014 - 2018 (USD Million)
  • TABLE 1608: UAE hemophilia treatment market size, by adult, 2019 - 2025 (USD Million)
  • TABLE 1609: UAE hemophilia treatment market size, by treatment, 2014 - 2018 (USD Million)
  • TABLE 1610: UAE hemophilia treatment market size, by treatment, 2019 - 2025 (USD Million)
  • TABLE 1611: UAE hemophilia treatment market size, by therapy, 2014 - 2018 (USD Million)
  • TABLE 1612: UAE hemophilia treatment market size, by therapy, 2019 - 2025 (USD Million)
  • TABLE 1613: UAE hemophilia treatment market size, by drug class, 2014 - 2018 (USD Million)
  • TABLE 1614: UAE hemophilia treatment market size, by drug class, 2019 - 2025 (USD Million)
  • TABLE 1615: UAE hemophilia treatment market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 1616: UAE hemophilia treatment market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 1617: UAE hemophilia treatment market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 1618: UAE hemophilia treatment market size, by end-use, 2019 - 2025 (USD Million)

Charts & Figures

  • FIG. 1: Industry segmentation
  • FIG. 2: Global hemophilia treatment market, 2014 - 2025 (USD Million)
  • FIG. 3: Growth potential analysis, by disease
  • FIG. 4: Growth potential analysis, by product
  • FIG. 5: Growth potential analysis, by patient
  • FIG. 6: Growth potential analysis, by treatment
  • FIG. 7: Growth potential analysis, by therapy
  • FIG. 8: Growth potential analysis, by drug class
  • FIG. 9: Growth potential analysis, by route of administration
  • FIG. 10: Growth potential analysis, by end-use
  • FIG. 11: Global hemophilia prevalence, 2018
  • FIG. 12: Global hemophilia A prevalence, 2018
  • FIG. 13: Global hemophilia B prevalence, 2018
  • FIG. 14: Porter's analysis
  • FIG. 15: Strategy dashboard
  • FIG. 16: PESTEL analysis
  • FIG. 17: North America hemophilia prevalence, 2014 - 2025
  • FIG. 18: U.S. hemophilia prevalence, 2014 - 2025
  • FIG. 19: Canada hemophilia prevalence, 2014 - 2025
  • FIG. 20: Europe hemophilia prevalence, 2014 - 2025
  • FIG. 21: Germany hemophilia prevalence, 2014 - 2025
  • FIG. 22: UK hemophilia prevalence, 2014 - 2025
  • FIG. 23: France hemophilia prevalence, 2014 - 2025
  • FIG. 24: Spain hemophilia prevalence, 2014 - 2025
  • FIG. 25: Italy hemophilia prevalence, 2014 - 2025
  • FIG. 26: Russia hemophilia prevalence, 2014 - 2025
  • FIG. 27: Poland hemophilia prevalence, 2014 - 2025
  • FIG. 28: Hungary hemophilia prevalence, 2014 - 2025
  • FIG. 29: Czech Republic hemophilia prevalence, 2014 - 2025
  • FIG. 30: Finland hemophilia prevalence, 2014 - 2025
  • FIG. 31: Greece hemophilia prevalence, 2014 - 2025
  • FIG. 32: Ireland hemophilia prevalence, 2014 - 2025
  • FIG. 33: Portugal hemophilia prevalence, 2014 - 2025
  • FIG. 34: Sweden hemophilia prevalence, 2014 - 2025
  • FIG. 35: Switzerland hemophilia prevalence, 2014 - 2025
  • FIG. 36: Ukraine hemophilia prevalence, 2014 - 2025
  • FIG. 37: Norway hemophilia prevalence, 2014 - 2025
  • FIG. 38: Slovakia hemophilia prevalence, 2014 - 2025
  • FIG. 39: Asia Pacific hemophilia prevalence, 2014 - 2025
  • FIG. 40: China hemophilia prevalence, 2014 - 2025
  • FIG. 41: Japan hemophilia prevalence, 2014 - 2025
  • FIG. 42: India hemophilia prevalence, 2014 - 2025
  • FIG. 43: Australia hemophilia prevalence, 2014 - 2025
  • FIG. 44: South Korea hemophilia prevalence, 2014 - 2025
  • FIG. 45: Malaysia hemophilia prevalence, 2014 - 2025
  • FIG. 46: Philippines hemophilia prevalence, 2014 - 2025
  • FIG. 47: Thailand hemophilia prevalence, 2014 - 2025
  • FIG. 48: Vietnam hemophilia prevalence, 2014 - 2025
  • FIG. 49: Singapore hemophilia prevalence, 2014 - 2025
  • FIG. 50: Latin America hemophilia prevalence, 2014 - 2025
  • FIG. 51: Brazil hemophilia prevalence, 2014 - 2025
  • FIG. 52: Mexico hemophilia prevalence, 2014 - 2025
  • FIG. 53: Argentina hemophilia prevalence, 2014 - 2025
  • FIG. 54: Columbia hemophilia prevalence, 2014 - 2025
  • FIG. 55: Chile hemophilia prevalence, 2014 - 2025
  • FIG. 56: Venezuela hemophilia prevalence, 2014 - 2025
  • FIG. 57: MEA hemophilia prevalence, 2014 - 2025
  • FIG. 58: South Africa hemophilia prevalence, 2014 - 2025
  • FIG. 59: Saudi Arabia hemophilia prevalence, 2014 - 2025
  • FIG. 60: Egypt hemophilia prevalence, 2014 - 2025
  • FIG. 61: Iran hemophilia prevalence, 2014 - 2025
  • FIG. 62: Iraq hemophilia prevalence, 2014 - 2025
  • FIG. 63: UAE hemophilia prevalence, 2014 - 2025
目次
Product Code: 2772

Title:
Hemophilia Treatment Market Size By Disease (Hemophilia A {Severe, Moderate, Mild}, Hemophilia B {Severe, Moderate, Mild}), By Product (Recombinant Factor Concentrates {Factor VIII, Factor IX}, Plasma-derived Factor Concentrates {Factor VIII, Factor IX}, Extended Half-life Products {Factor VIII, Factor IX}), By Patient (Pediatric {0 to 4, 5 to 13, 14 to18}, Adult {19 to 44, 45+}), By Treatment (Prophylaxis, On Demand), By Therapy (Factor Replacement Therapy, Non-factor Replacement Therapy), By Drug Class (Vasopressin, Coagulation Factors), By Route of Administration (Injectable, Nasal Spray), By End-use (Hospitals, Clinics, Hemophilia Treatment Centers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Poland, Hungary, Czech Republic, Finland, Greece, Ireland, Portugal, Sweden, Switzerland, Ukraine, Norway, Slovakia, China, Japan, India, Australia, South Korea, Malaysia, Philippines, Thailand, Vietnam, Singapore, Brazil, Mexico, Argentina, Columbia, Chile, Venezuela, South Africa, Saudi Arabia, Egypt, Iran, Iraq, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025.

Hemophilia Treatment Market will exceed USD 14.8 billion by 2025; as per a new research report.

Increasing burden of bleeding disorders including hemophilia will stimulate global hemophilia treatment market growth in upcoming years. According to the World Federation of Hemophilia, the global prevalence of hemophilia was depicted to be around 184,723 in the year 2016. Currently, the number of individuals in the U.S. suffering from hemophilia is predicted to be about 20,000. Individuals with hemophilia A is anticipated to be around 149,764 and individuals with hemophilia B are around 29,712. According to the Center for Disease Control and Prevention, average age for diagnosis of hemophilia is 36 months for mild hemophilia, 8 months for moderate hemophilia and 1 month for severe hemophilia. Thus, rise in prevalence of hemophilia will boost the hemophilia treatment business growth in the forthcoming period.

Rise in initiatives and educational programs by the government will further boost the hemophilia treatment market. Organizations such as World Federation of Hemophilia (WFH) along with government of several countries carry out diagnosis program. One such program is Cornerstone initiative by WFH for underprivileged people. Furthermore, increase in R&D activities along with novel drug launches will upsurge the growth of hemophilia treatment market; for instance, gene therapy is under clinical investigation.

Additionally, increasing adoption of prophylaxis treatment by individuals suffering from hemophilia is contributing to the growth of the market. However, high-costs associated with hemophilia drugs will limit the growth of hemophilia treatment market. Furthermore, lack of awareness and adequate treatment in developing and under-developed countries will have negative impact on the market growth.

Hemophilia A segment will hold a notable revenue size of USD 6,743.7 million in the year 2018. The prevalence rate is high in developing and underdeveloped economies. According to the National Hemophilia Foundation, hemophilia A is four times more common than hemophilia B. Thus, increase in number of individuals suffering from hemophilia A along with rise in awareness regarding treatment of hemophilia will positively impact the growth of segment.

Recombinant coagulation factor concentrates market is estimated to dominate the market in the coming years and grow at 5% over the estimation period. Additionally, recombinant coagulation factor concentrates have a low risk of transmitting an infectious disease and are used to prevent viral infection. Also, recombinant coagulation factor concentrates increases the safety of replacement therapy, increasing its adoption rate leading to increased business growth over the forecast period.

Prophylaxis treatment market segment will hold a significant revenue size of USD 7,219.9 million in 2018 and is estimated to hold majority market share over the forthcoming years owing to rise in adoption of prophylaxis treatment. Patients with severe hemophilia are recommended prophylactic treatment to avoid bleeding episodes. Furthermore, some recent studies have proven prophylactic treatment to be quite effective with incidence of joint pain getting reduced by prophylactic treatment. Thus, better efficacy and merits over other treatment will increase its adoption rate, thereby leading to upsurge in prophylaxis segment revenue.

Factor replacement therapy market will grow at a significant pace owing to its preference over other therapies. Recombinant factor replacement therapy is the first line treatment for patients with moderate to severe hemophilia. Increasing R&D investments and new drug launch in replacement therapy is estimated to drive the growth of segment. Furthermore, increasing awareness amongst the patients regarding factor replacement therapy will boost the market growth.

Coagulation factors market held a significant market share and was valued at USD 9,948.3 million in the year 2018. Coagulation factors are used in replacement therapy. The rise in prevalence of moderate to severe hemophilia will spur the demand of replacement therapy, thereby boosting the demand for coagulation factors.

Injectables route of administration is projected to witness growth at 5% over the estimation period owing to majority of medications that are dispensed in injectable form. Also, bioavailability of intravenously administered drug is 100%, thus, intravenous route is preferable for quick action. Nasal spray segment is anticipated to foresee momentous growth in the coming years due to various advantages offered by nasal route over injectables such as ease of administration.

Hemophilia treatment in adult will dominate the patient segment and was valued at USD 6,778.2 million in 2018, due to rise in prevalence of hemophilia in adults. According to one recent article, around 65% of the individuals suffering from hemophilia are adults. Also, the chances of developing moderate to severe hemophilia are high in adults. Thus, growing age results in high occurrence of hemophilia, thereby impacting the growth of segment.

Hemophilia treatment centers (HTCs) is expected to grow at 4.6% in the coming years owing to increase preference of these centers over hospitals and clinics. Hemophilia treatment centers are primarily aimed to provide comprehensive hemophilia treatment to the underprivileged patients. Additionally, HTCs focus on organizing initiatives for spreading awareness regarding hemophilia in developing and under-developed countries. Also, special care provided by HTC's will increase its preference, thereby fueling its growth.

U.S. hemophilia treatment market was valued at USD 3,539.3 million in the year 2018. According to the National Hemophilia Foundation, the number of individuals suffering with hemophilia are estimated to be around 20,000. Furthermore, favorable reimbursement policies provided by hemophilia treatment centers and insurance in the country will raise the adoption rates of hemophilia treatment.

India hemophilia treatment market is expected to grow at 9.2% in the coming years owing to rise in awareness regarding hemophilia treatment in developing economies. Furthermore, rise in government initiatives, increase in healthcare expenditure and educational programs conducted by government will further increase the market growth.

Some of the major players involved in the global hemophilia treatment market are Sanofi SA, Swedeish Orphan Biovitrum AB, Biotest AG., Genentech, among others. Companies are implementing several business strategies such as strategic collaborations, mergers and acquisition to increase their product portfolio and market footprint. For instance, in June 2018, Biotest opened two plasma collection centers in Czech Republic to complement its plasma collection capacity.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definition
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Hemophilia treatment industry 360 degree synopsis, 2014 - 2025 (USD Million)
    • 2.1.1. Business trends
    • 2.1.2. Disease trends
    • 2.1.3. Product trends
    • 2.1.4. Patient trends
    • 2.1.5. Treatment trends
    • 2.1.6. Therapy trends
    • 2.1.7. Drug class trends
    • 2.1.8. Route of administration trends
    • 2.1.9. End-use trends
    • 2.1.10. Regional trends

Chapter 3. Hemophilia Treatment Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2014 - 2025 (USD Million)
  • 3.3. Industry impact factors
    • 3.3.1. Growth drivers
      • 3.3.1.1. Growing prevalence of hemophilia across the globe
      • 3.3.1.2. Rise in favourable government initiatives
      • 3.3.1.3. Increase in R&D and new product development
      • 3.3.1.4. Growing adoption of prophylaxis treatment
      • 3.3.1.5. Upsurge in hemophilia prevalence in new-borns
      • 3.3.1.6. Introduction of new drug launches
      • 3.3.1.7. Rise in hemophilia inhibitors
    • 3.3.2. Industry pitfalls & challenges
      • 3.3.2.1. High cost associated with hemophilia treatment
      • 3.3.2.2. Lack of awareness in developing and under-developed regions
      • 3.3.2.3. Low adoption rates of technologically advanced products
  • 3.4. Growth potential analysis
    • 3.4.1. By disease
    • 3.4.2. By product
    • 3.4.3. By patient
    • 3.4.4. By treatment
    • 3.4.5. By therapy
    • 3.4.6. By drug class
    • 3.4.7. By route of administration
    • 3.4.8. By end-use
  • 3.5. Regulatory landscape
    • 3.5.1. U.S.
    • 3.5.2. Europe
  • 3.6. Global hemophilia prevalence, 2018
    • 3.6.1. Global hemophilia A prevalence, 2018
    • 3.6.2. Global hemophilia B prevalence, 2018
  • 3.7. Product pipeline analysis
    • 3.7.1. Factor concentrates
    • 3.7.2. Inhibitors
    • 3.7.3. Non-factor coagulation products
    • 3.7.4. Gene therapy
  • 3.8. Porter's analysis
  • 3.9. Competitive landscape, 2017
    • 3.9.1. Strategy dashboard
  • 3.10. PESTEL analysis

Chapter 4. Hemophilia Treatment Market, By Disease

  • 4.1. Global hemophilia treatment market share by disease, 2018 & 2025
  • 4.2. Hemophilia A
    • 4.2.1. Market size, by region, 2014 - 2025 (USD Million)
    • 4.2.2. Severe
      • 4.2.2.1. Market size, by region, 2014 - 2025 (USD Million)
    • 4.2.3. Moderate
      • 4.2.3.1. Market size, by region, 2014 - 2025 (USD Million)
    • 4.2.4. Mild
      • 4.2.4.1. Market size, by region, 2014 - 2025 (USD Million)
  • 4.3. Hemophilia B
    • 4.3.1. Market size, by region, 2014 - 2025 (USD Million)
    • 4.3.2. Severe
      • 4.3.2.1. Market size, by region, 2014 - 2025 (USD Million)
    • 4.3.3. Moderate
      • 4.3.3.1. Market size, by region, 2014 - 2025 (USD Million)
    • 4.3.4. Mild
      • 4.3.4.1. Market size, by region, 2014 - 2025 (USD Million)
  • 4.4. Others
    • 4.4.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 5. Hemophilia Treatment Market, By Product

  • 5.1. Global hemophilia treatment market share by product, 2018 & 2025
  • 5.2. Recombinant Factor Concentrates
    • 5.2.1. Market size, by region, 2014 - 2025 (USD Million)
    • 5.2.2. Factor VIII
      • 5.2.2.1. Market size, by region, 2014 - 2025 (USD Million)
    • 5.2.3. Factor IX
      • 5.2.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.3. Plasma-derived Factor Concentrates
    • 5.3.1. Market size, by region, 2014 - 2025 (USD Million)
    • 5.3.2. Factor VIII
      • 5.3.2.1. Market size, by region, 2014 - 2025 (USD Million)
    • 5.3.3. Factor IX
      • 5.3.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.4. Extended Half-life Products
    • 5.4.1. Market size, by region, 2014 - 2025 (USD Million)
    • 5.4.2. Factor VIII
      • 5.4.2.1. Market size, by region, 2014 - 2025 (USD Million)
    • 5.4.3. Factor IX
      • 5.4.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.5. Others
    • 5.5.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 6. Hemophilia Treatment Market, By Patient

  • 6.1. Global hemophilia treatment market share by patient, 2018 & 2025
  • 6.2. Pediatric
    • 6.2.1. Market size, by region, 2014 - 2025 (USD Million)
    • 6.2.2. 0 to 4 years
      • 6.2.2.1. Market size, by region, 2014 - 2025 (USD Million)
    • 6.2.3. 5 to 13 years
      • 6.2.3.1. Market size, by region, 2014 - 2025 (USD Million)
    • 6.2.4. 14 to 18 years
      • 6.2.4.1. Market size, by region, 2014 - 2025 (USD Million)
  • 6.3. Adult
    • 6.3.1. Market size, by region, 2014 - 2025 (USD Million)
    • 6.3.2. 19 to 44
      • 6.3.2.1. Market size, by region, 2014 - 2025 (USD Million)
    • 6.3.3. 45+
      • 6.3.3.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 7. Hemophilia Treatment Market, By Treatment

  • 7.1. Global hemophilia treatment market share by treatment, 2018 & 2025
  • 7.2. Prophylaxis
    • 7.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 7.3. On Demand
    • 7.3.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 8. Hemophilia Treatment Market, By Therapy

  • 8.1. Global hemophilia treatment market share by therapy, 2018 & 2025
  • 8.2. Factor Replacement Therapy
    • 8.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 8.3. Non-factor Replacement Therapy
    • 8.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 8.4. Others
    • 8.4.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 9. Hemophilia Treatment Market, By Drug Class

  • 9.1. Global hemophilia treatment market share by drug class, 2018 & 2025
  • 9.2. Vasopressin
    • 9.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 9.3. Coagulation Factors
    • 9.3.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 10. Hemophilia Treatment Market, By Route of Administration

  • 10.1. Global hemophilia treatment market share by route of administration, 2018 & 2025
  • 10.2. Injectable
    • 10.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 10.3. Nasal Spray
    • 10.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 10.4. Others
    • 10.4.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 11. Hemophilia Treatment Market, By End-use

  • 11.1. Global hemophilia treatment market share by end-use, 2018 & 2025
  • 11.2. Hospitals
    • 11.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 11.3. Clinics
    • 11.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 11.4. Hemophilia Treatment Centers
    • 11.4.1. Market size, by region, 2014 - 2025 (USD Million)
  • 11.5. Others
    • 11.5.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 12. Hemophilia Treatment Market, By Region

  • 12.1. Global hemophilia treatment market share by region, 2018 & 2025
  • 12.2. North America
    • 12.2.1. Hemophilia prevalence, by disease, 2014-2025
    • 12.2.2. Market size, by country, 2014 - 2025 (USD Million)
    • 12.2.3. Market size, by disease, 2014 - 2025 (USD Million)
      • 12.2.3.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
      • 12.2.3.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
    • 12.2.4. Market size, by product, 2014 - 2025 (USD Million)
      • 12.2.4.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
      • 12.2.4.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
      • 12.2.4.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
    • 12.2.5. Market size, by patient, 2014 - 2025 (USD Million)
      • 12.2.5.1. Market size, by pediatric, 2014 - 2025 (USD Million)
      • 12.2.5.2. Market size, by adult, 2014 - 2025 (USD Million)
    • 12.2.6. Market size, by treatment, 2014 - 2025 (USD Million)
    • 12.2.7. Market size, by therapy, 2014 - 2025 (USD Million)
    • 12.2.8. Market size, by drug class, 2014 - 2025 (USD Million)
    • 12.2.9. Market size, by route of administration, 2014 - 2025 (USD Million)
    • 12.2.10. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.2.11. U.S.
      • 12.2.11.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.2.11.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.2.11.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.2.11.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.2.11.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.2.11.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.2.11.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.2.11.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.2.11.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.2.11.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.2.11.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.2.11.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.2.11.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.2.11.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.2.11.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.2.11.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.2.12. Canada
      • 12.2.12.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.2.12.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.2.12.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.2.12.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.2.12.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.2.12.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.2.12.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.2.12.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.2.12.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.2.12.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.2.12.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.2.12.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.2.12.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.2.12.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.2.12.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.2.12.9. Market size, by end-use, 2014 - 2025 (USD Million)
  • 12.3. Europe
    • 12.3.1. Hemophilia prevalence, by disease, 2014-2025
    • 12.3.2. Market size, by country, 2014 - 2025 (USD Million)
    • 12.3.3. Market size, by disease, 2014 - 2025 (USD Million)
      • 12.3.3.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
      • 12.3.3.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
    • 12.3.4. Market size, by product, 2014 - 2025 (USD Million)
      • 12.3.4.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
      • 12.3.4.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
      • 12.3.4.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
    • 12.3.5. Market size, by patient, 2014 - 2025 (USD Million)
      • 12.3.5.1. Market size, by pediatric, 2014 - 2025 (USD Million)
      • 12.3.5.2. Market size, by adult, 2014 - 2025 (USD Million)
    • 12.3.6. Market size, by treatment, 2014 - 2025 (USD Million)
    • 12.3.7. Market size, by therapy, 2014 - 2025 (USD Million)
    • 12.3.8. Market size, by drug class, 2014 - 2025 (USD Million)
    • 12.3.9. Market size, by route of administration, 2014 - 2025 (USD Million)
    • 12.3.10. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.11. Germany
      • 12.3.11.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.11.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.11.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.11.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.11.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.11.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.11.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.11.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.11.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.11.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.11.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.11.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.11.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.11.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.11.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.11.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.12. UK
      • 12.3.12.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.12.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.12.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.12.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.12.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.12.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.12.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.12.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.12.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.12.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.12.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.12.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.12.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.12.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.12.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.12.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.13. France
      • 12.3.13.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.13.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.13.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.13.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.13.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.13.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.13.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.13.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.13.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.13.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.13.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.13.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.13.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.13.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.13.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.13.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.14. Spain
      • 12.3.14.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.14.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.14.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.14.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.14.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.14.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.14.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.14.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.14.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.14.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.14.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.14.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.14.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.14.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.14.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.14.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.15. Italy
      • 12.3.15.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.15.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.15.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.15.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.15.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.15.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.15.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.15.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.15.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.15.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.15.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.15.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.15.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.15.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.15.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.15.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.16. Russia
      • 12.3.16.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.16.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.16.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.16.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.16.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.16.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.16.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.16.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.16.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.16.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.16.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.16.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.16.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.16.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.16.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.16.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.17. Poland
      • 12.3.17.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.17.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.17.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.17.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.17.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.17.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.17.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.17.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.17.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.17.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.17.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.17.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.17.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.17.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.17.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.17.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.18. Hungary
      • 12.3.18.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.18.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.18.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.18.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.18.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.18.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.18.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.18.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.18.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.18.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.18.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.18.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.18.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.18.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.18.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.18.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.19. Czech Republic
      • 12.3.19.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.19.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.19.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.19.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.19.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.19.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.19.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.19.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.19.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.19.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.19.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.19.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.19.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.19.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.19.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.19.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.20. Finland
      • 12.3.20.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.20.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.20.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.20.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.20.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.20.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.20.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.20.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.20.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.20.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.20.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.20.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.20.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.20.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.20.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.20.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.21. Greece
      • 12.3.21.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.21.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.21.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.21.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.21.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.21.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.21.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.21.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.21.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.21.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.21.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.21.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.21.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.21.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.21.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.21.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.22. Ireland
      • 12.3.22.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.22.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.22.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.22.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.22.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.22.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.22.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.22.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.22.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.22.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.22.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.22.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.22.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.22.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.22.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.22.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.23. Portugal
      • 12.3.23.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.23.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.23.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.23.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.23.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.23.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.23.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.23.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.23.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.23.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.23.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.23.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.23.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.23.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.23.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.23.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.24. Sweden
      • 12.3.24.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.24.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.24.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.24.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.24.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.24.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.24.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.24.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.24.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.24.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.24.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.24.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.24.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.24.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.24.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.24.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.25. Switzerland
      • 12.3.25.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.25.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.25.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.25.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.25.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.25.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.25.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.25.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.25.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.25.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.25.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.25.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.25.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.25.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.25.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.25.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.26. Ukraine
      • 12.3.26.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.26.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.26.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.26.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.26.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.26.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.26.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.26.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.26.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.26.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.26.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.26.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.26.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.26.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.26.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.26.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.27. Norway
      • 12.3.27.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.27.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.27.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.27.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.27.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.27.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.27.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.27.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.27.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.27.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.27.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.27.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.27.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.27.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.27.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.27.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.3.28. Slovakia
      • 12.3.28.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.3.28.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.3.28.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.3.28.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.3.28.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.3.28.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.28.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.3.28.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.3.28.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.3.28.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.3.28.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.3.28.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.3.28.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.3.28.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.3.28.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.3.28.9. Market size, by end-use, 2014 - 2025 (USD Million)
  • 12.4. Asia Pacific
    • 12.4.1. Hemophilia prevalence, by disease, 2014-2025
    • 12.4.2. Market size, by country, 2014 - 2025 (USD Million)
    • 12.4.3. Market size, by disease, 2014 - 2025 (USD Million)
      • 12.4.3.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
      • 12.4.3.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
    • 12.4.4. Market size, by product, 2014 - 2025 (USD Million)
      • 12.4.4.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
      • 12.4.4.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
      • 12.4.4.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
    • 12.4.5. Market size, by patient, 2014 - 2025 (USD Million)
      • 12.4.5.1. Market size, by pediatric, 2014 - 2025 (USD Million)
      • 12.4.5.2. Market size, by adult, 2014 - 2025 (USD Million)
    • 12.4.6. Market size, by treatment, 2014 - 2025 (USD Million)
    • 12.4.7. Market size, by therapy, 2014 - 2025 (USD Million)
    • 12.4.8. Market size, by drug class, 2014 - 2025 (USD Million)
    • 12.4.9. Market size, by route of administration, 2014 - 2025 (USD Million)
    • 12.4.10. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.4.11. China
      • 12.4.11.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.4.11.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.4.11.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.4.11.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.4.11.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.4.11.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.11.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.11.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.4.11.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.4.11.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.4.11.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.4.11.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.4.11.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.4.11.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.4.11.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.4.11.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.4.12. Japan
      • 12.4.12.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.4.12.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.4.12.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.4.12.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.4.12.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.4.12.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.12.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.12.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.4.12.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.4.12.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.4.12.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.4.12.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.4.12.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.4.12.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.4.12.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.4.12.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.4.13. India
      • 12.4.13.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.4.13.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.4.13.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.4.13.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.4.13.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.4.13.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.13.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.13.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.4.13.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.4.13.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.4.13.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.4.13.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.4.13.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.4.13.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.4.13.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.4.13.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.4.14. Australia
      • 12.4.14.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.4.14.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.4.14.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.4.14.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.4.14.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.4.14.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.14.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.14.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.4.14.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.4.14.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.4.14.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.4.14.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.4.14.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.4.14.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.4.14.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.4.14.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.4.15. South Korea
      • 12.4.15.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.4.15.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.4.15.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.4.15.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.4.15.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.4.15.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.15.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.15.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.4.15.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.4.15.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.4.15.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.4.15.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.4.15.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.4.15.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.4.15.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.4.15.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.4.16. Malaysia
      • 12.4.16.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.4.16.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.4.16.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.4.16.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.4.16.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.4.16.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.16.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.16.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.4.16.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.4.16.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.4.16.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.4.16.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.4.16.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.4.16.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.4.16.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.4.16.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.4.17. Philippines
      • 12.4.17.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.4.17.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.4.17.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.4.17.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.4.17.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.4.17.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.17.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.17.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.4.17.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.4.17.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.4.17.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.4.17.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.4.17.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.4.17.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.4.17.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.4.17.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.4.18. Thailand
      • 12.4.18.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.4.18.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.4.18.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.4.18.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.4.18.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.4.18.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.18.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.18.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.4.18.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.4.18.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.4.18.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.4.18.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.4.18.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.4.18.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.4.18.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.4.18.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.4.19. Vietnam
      • 12.4.19.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.4.19.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.4.19.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.4.19.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.4.19.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.4.19.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.19.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.19.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.4.19.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.4.19.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.4.19.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.4.19.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.4.19.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.4.19.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.4.19.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.4.19.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.4.20. Singapore
      • 12.4.20.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.4.20.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.4.20.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.4.20.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.4.20.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.4.20.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.20.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.4.20.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.4.20.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.4.20.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.4.20.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.4.20.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.4.20.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.4.20.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.4.20.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.4.20.9. Market size, by end-use, 2014 - 2025 (USD Million)
  • 12.5. Latin America
    • 12.5.1. Hemophilia prevalence, by disease, 2014-2025
    • 12.5.2. Market size, by country, 2014 - 2025 (USD Million)
    • 12.5.3. Market size, by disease, 2014 - 2025 (USD Million)
      • 12.5.3.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
      • 12.5.3.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
    • 12.5.4. Market size, by product, 2014 - 2025 (USD Million)
      • 12.5.4.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
      • 12.5.4.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
      • 12.5.4.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
    • 12.5.5. Market size, by patient, 2014 - 2025 (USD Million)
      • 12.5.5.1. Market size, by pediatric, 2014 - 2025 (USD Million)
      • 12.5.5.2. Market size, by adult, 2014 - 2025 (USD Million)
    • 12.5.6. Market size, by treatment, 2014 - 2025 (USD Million)
    • 12.5.7. Market size, by therapy, 2014 - 2025 (USD Million)
    • 12.5.8. Market size, by drug class, 2014 - 2025 (USD Million)
    • 12.5.9. Market size, by route of administration, 2014 - 2025 (USD Million)
    • 12.5.10. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.5.11. Brazil
      • 12.5.11.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.5.11.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.5.11.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.5.11.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.5.11.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.5.11.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.5.11.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.5.11.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.5.11.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.5.11.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.5.11.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.5.11.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.5.11.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.5.11.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.5.11.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.5.11.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.5.12. Mexico
      • 12.5.12.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.5.12.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.5.12.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.5.12.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.5.12.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.5.12.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.5.12.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.5.12.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.5.12.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.5.12.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.5.12.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.5.12.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.5.12.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.5.12.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.5.12.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.5.12.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.5.13. Argentina
      • 12.5.13.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.5.13.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.5.13.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.5.13.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.5.13.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.5.13.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.5.13.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.5.13.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.5.13.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.5.13.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.5.13.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.5.13.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.5.13.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.5.13.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.5.13.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.5.13.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.5.14. Columbia
      • 12.5.14.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.5.14.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.5.14.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.5.14.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.5.14.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.5.14.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.5.14.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.5.14.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.5.14.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.5.14.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.5.14.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.5.14.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.5.14.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.5.14.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.5.14.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.5.14.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.5.15. Chile
      • 12.5.15.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.5.15.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.5.15.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.5.15.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.5.15.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.5.15.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.5.15.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.5.15.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.5.15.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.5.15.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.5.15.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.5.15.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.5.15.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.5.15.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.5.15.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.5.15.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.5.16. Venezuela
      • 12.5.16.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.5.16.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.5.16.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.5.16.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.5.16.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.5.16.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.5.16.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.5.16.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.5.16.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.5.16.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.5.16.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.5.16.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.5.16.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.5.16.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.5.16.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.5.16.9. Market size, by end-use, 2014 - 2025 (USD Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Hemophilia prevalence, by disease, 2014-2025
    • 12.6.2. Market size, by country, 2014 - 2025 (USD Million)
    • 12.6.3. Market size, by disease, 2014 - 2025 (USD Million)
      • 12.6.3.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
      • 12.6.3.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
    • 12.6.4. Market size, by product, 2014 - 2025 (USD Million)
      • 12.6.4.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
      • 12.6.4.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
      • 12.6.4.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
    • 12.6.5. Market size, by patient, 2014 - 2025 (USD Million)
      • 12.6.5.1. Market size, by pediatric, 2014 - 2025 (USD Million)
      • 12.6.5.2. Market size, by adult, 2014 - 2025 (USD Million)
    • 12.6.6. Market size, by treatment, 2014 - 2025 (USD Million)
    • 12.6.7. Market size, by therapy, 2014 - 2025 (USD Million)
    • 12.6.8. Market size, by drug class, 2014 - 2025 (USD Million)
    • 12.6.9. Market size, by route of administration, 2014 - 2025 (USD Million)
    • 12.6.10. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.6.11. South Africa
      • 12.6.11.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.6.11.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.6.11.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.6.11.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.6.11.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.6.11.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.6.11.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.6.11.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.6.11.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.6.11.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.6.11.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.6.11.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.6.11.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.6.11.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.6.11.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.6.11.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.6.12. Saudi Arabia
      • 12.6.12.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.6.12.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.6.12.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.6.12.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.6.12.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.6.12.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.6.12.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.6.12.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.6.12.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.6.12.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.6.12.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.6.12.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.6.12.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.6.12.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.6.12.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.6.12.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.6.13. Egypt
      • 12.6.13.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.6.13.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.6.13.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.6.13.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.6.13.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.6.13.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.6.13.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.6.13.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.6.13.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.6.13.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.6.13.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.6.13.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.6.13.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.6.13.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.6.13.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.6.13.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.6.14. Iran
      • 12.6.14.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.6.14.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.6.14.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.6.14.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.6.14.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.6.14.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.6.14.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.6.14.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.6.14.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.6.14.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.6.14.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.6.14.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.6.14.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.6.14.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.6.14.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.6.14.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.6.15. Iraq
      • 12.6.15.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.6.15.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.6.15.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.6.15.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.6.15.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.6.15.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.6.15.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.6.15.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.6.15.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.6.15.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.6.15.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.6.15.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.6.15.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.6.15.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.6.15.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.6.15.9. Market size, by end-use, 2014 - 2025 (USD Million)
    • 12.6.16. UAE
      • 12.6.16.1. Hemophilia prevalence, by disease, 2014-2025
      • 12.6.16.2. Market size, by disease, 2014 - 2025 (USD Million)
        • 12.6.16.2.1. Market size, by hemophilia A, 2014 - 2025 (USD Million)
        • 12.6.16.2.2. Market size, by hemophilia B, 2014 - 2025 (USD Million)
      • 12.6.16.3. Market size, by product, 2014 - 2025 (USD Million)
        • 12.6.16.3.1. Market size, by recombinant factor concentrates, 2014 - 2025 (USD Million)
        • 12.6.16.3.2. Market size, by plasma-derived factor concentrates, 2014 - 2025 (USD Million)
        • 12.6.16.3.3. Market size, by extended half-life products, 2014 - 2025 (USD Million)
      • 12.6.16.4. Market size, by patient, 2014 - 2025 (USD Million)
        • 12.6.16.4.1. Market size, by pediatric, 2014 - 2025 (USD Million)
        • 12.6.16.4.2. Market size, by adult, 2014 - 2025 (USD Million)
      • 12.6.16.5. Market size, by treatment, 2014 - 2025 (USD Million)
      • 12.6.16.6. Market size, by therapy, 2014 - 2025 (USD Million)
      • 12.6.16.7. Market size, by drug class, 2014 - 2025 (USD Million)
      • 12.6.16.8. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 12.6.16.9. Market size, by end-use, 2014 - 2025 (USD Million)

Chapter 13. Company Profiles

  • 13.1. Bayer Healthcare
    • 13.1.1. Business overview
    • 13.1.2. Financial data
    • 13.1.3. Product landscape
    • 13.1.4. Strategic outlook
    • 13.1.5. SWOT analysis
  • 13.2. Biogen
    • 13.2.1. Business overview
    • 13.2.2. Financial data
    • 13.2.3. Product landscape
    • 13.2.4. Strategic outlook
    • 13.2.5. SWOT analysis
  • 13.3. Biotest AG
    • 13.3.1. Business overview
    • 13.3.2. Financial data
    • 13.3.3. Product landscape
    • 13.3.4. Strategic outlook
    • 13.3.5. SWOT analysis
  • 13.4. CSL Behring
    • 13.4.1. Business overview
    • 13.4.2. Financial data
    • 13.4.3. Product landscape
    • 13.4.4. Strategic outlook
    • 13.4.5. SWOT analysis
  • 13.5. Ferring B.V.
    • 13.5.1. Business overview
    • 13.5.2. Financial data
    • 13.5.3. Product landscape
    • 13.5.4. Strategic outlook
    • 13.5.5. SWOT analysis
  • 13.6. Genentech
    • 13.6.1. Business overview
    • 13.6.2. Financial data
    • 13.6.3. Product landscape
    • 13.6.4. Strategic outlook
    • 13.6.5. SWOT analysis
  • 13.7. Kedrion
    • 13.7.1. Business overview
    • 13.7.2. Financial data
    • 13.7.3. Product landscape
    • 13.7.4. Strategic outlook
    • 13.7.5. SWOT analysis
  • 13.8. Novo Nordisk
    • 13.8.1. Business overview
    • 13.8.2. Financial data
    • 13.8.3. Product landscape
    • 13.8.4. Strategic outlook
    • 13.8.5. SWOT analysis
  • 13.9. Octapharma
    • 13.9.1. Business overview
    • 13.9.2. Financial data
    • 13.9.3. Product landscape
    • 13.9.4. Strategic outlook
    • 13.9.5. SWOT analysis
  • 13.10. Pfizer
    • 13.10.1. Business overview
    • 13.10.2. Financial data
    • 13.10.3. Product landscape
    • 13.10.4. Strategic outlook
    • 13.10.5. SWOT analysis
  • 13.11. Sanofi SA
    • 13.11.1. Business overview
    • 13.11.2. Financial data
    • 13.11.3. Product landscape
    • 13.11.4. Strategic outlook
    • 13.11.5. SWOT analysis
  • 13.12. Swedish Orphan Biovitrum AB
    • 13.12.1. Business overview
    • 13.12.2. Financial data
    • 13.12.3. Product landscape
    • 13.12.4. Strategic outlook
    • 13.12.5. SWOT analysis
Back to Top